Notes
Identifying patient details (age and sex) have been obtained through direct communication with the author.
Reference
Hu Y, et al. Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system. International Immunopharmacology 84: Jul 2020. Available from: URL: http://doi.org/10.1016/j.intimp.2020.106601
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1809, 38 (2020). https://doi.org/10.1007/s40278-020-79822-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79822-6